• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

托珠单抗治疗居家治疗的 SARS-CoV-2 感染:病例报告。

Tocilizumab for treatment of SARS-CoV-2 infection at home: A case report.

机构信息

MPharm, Oxford University Hospitals NHS Foundation Trust.

DPhil, Oxford University Hospitals NHS Foundation Trust and Nuffield Department of Medicine, University of Oxford.

出版信息

Acute Med. 2022;21(1):53-55. doi: 10.52964/AMJA.0894.

DOI:10.52964/AMJA.0894
PMID:35342912
Abstract

SARS-CoV-2 virtual wards have successfully developed to monitor and escalate patients to hospital throughout the pandemic. Here we describe the case of an 84 year old man who received his complete care for severe SARS-CoV-2 pneumonitis at home, including the administration of oxygen, dexamethasone and tocilizumab.

摘要

SARS-CoV-2 虚拟病房在大流行期间成功开发,用于监测和将患者升级到医院。在这里,我们描述了一名 84 岁男性的病例,他在家中接受了严重 SARS-CoV-2 肺炎的全面治疗,包括吸氧、地塞米松和托珠单抗治疗。

相似文献

1
Tocilizumab for treatment of SARS-CoV-2 infection at home: A case report.托珠单抗治疗居家治疗的 SARS-CoV-2 感染:病例报告。
Acute Med. 2022;21(1):53-55. doi: 10.52964/AMJA.0894.
2
Special case of a patient in the blast phase of chronic myeloid leukemia successfully treated with tocilizumab during critical SARS-CoV-2 infection.慢性髓性白血病急变期患者在严重 SARS-CoV-2 感染期间成功接受托珠单抗治疗的特殊病例。
J Int Med Res. 2022 Mar;50(3):3000605221082875. doi: 10.1177/03000605221082875.
3
Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment.托珠单抗治疗期间伴 MOG 抗体相关疾病的良性 SARS-CoV-2 感染。
Mult Scler Relat Disord. 2020 Nov;46:102592. doi: 10.1016/j.msard.2020.102592. Epub 2020 Oct 21.
4
Secondary Infection Risk in Patients With Severe COVID-19 Pneumonia Treated With Tocilizumab.托珠单抗治疗的重症新型冠状病毒肺炎患者的继发感染风险
Am J Ther. 2022;29(3):e275-e278. doi: 10.1097/MJT.0000000000001487. Epub 2022 Mar 4.
5
Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19.严重 COVID-19 的调整剂量地塞米松和托珠单抗联合治疗。
Yonsei Med J. 2022 May;63(5):430-439. doi: 10.3349/ymj.2022.63.5.430.
6
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab.阿那白滞素作为治疗对托珠单抗难治的 SARS-CoV-2 相关严重急性呼吸道感染的一种潜在替代药物。
Reumatol Clin (Engl Ed). 2021 Dec;17(10):559-561. doi: 10.1016/j.reumae.2020.06.008. Epub 2020 Oct 15.
7
Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab.镰状细胞病合并近期 SARS-CoV-2 感染患者出现严重溶血,经复杂的自身抗体和同种异体抗体检测,并用托珠单抗成功治疗。
Transfusion. 2022 Jul;62(7):1446-1451. doi: 10.1111/trf.16932. Epub 2022 May 30.
8
Tocilizumab administration in patients with SARS-CoV-2 infection: Subcutaneous injection vs intravenous infusion.托珠单抗用于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染患者:皮下注射与静脉输注对比
J Med Virol. 2021 Jan;93(1):69-70. doi: 10.1002/jmv.26124. Epub 2020 Jun 19.
9
Tocilizumab: From Rheumatic Diseases to COVID-19.托珠单抗:从风湿性疾病到 COVID-19。
Curr Pharm Des. 2021;27(13):1597-1607. doi: 10.2174/1381612827666210311141512.
10
Predictors of poor outcome in tocilizumab treated patients with Sars-CoV-2 related severe respiratory failure: A multicentre real world study.托珠单抗治疗 SARS-CoV-2 相关严重呼吸衰竭患者预后不良的预测因素:一项多中心真实世界研究。
Int Immunopharmacol. 2022 Jun;107:108709. doi: 10.1016/j.intimp.2022.108709. Epub 2022 Mar 18.